Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent

Intensive Care Medicine

Volumn 28, Issue 5, 2002, Pages 586-593

  Fiaccadori, Enrico ^a   Maggiore, Umberto ^a   Rotelli, Carlo ^a   Minari, Marilena ^a   Melfa, Luigi ^a   Cappè, Giacomo ^a   Cabassi, Aderville ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Acute renal failure; Coagulation; Continuous haemofiltration; Critical illness; Haemorrhage; Platelets; Prostacyclin

Indexed keywords

PROSTACYCLIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BLOOD FLOW VELOCITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; EXTRACORPOREAL CIRCULATION; FEMALE; HEMODYNAMICS; HEMOFILTRATION; HOSPITALIZATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; TEACHING HOSPITAL;

AGED; ANALYSIS OF VARIANCE; CRITICAL ILLNESS; EPOPROSTENOL; FEMALE; HEMOFILTRATION; HEMORRHAGE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036266277     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-002-1249-y     Document Type: Article

References (47)

1. Renal replacement therapy for acute renal failure
2. Anticoagulation in continuous renal replacement therapy
3. Anticoagulation for continuous renal replacement therapy
4. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute and hepatic failure
5. Anticoagulation in patients treated by continuous venovenous hemofiltration: A retrospective study
6. Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage
7. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients
8. Regional heparinization for continuous arterio-venous hemofiltration (CAVH)
9. Extracorporeal management of acute renal failure patients at high risk of bleeding
10. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration
11. Continuous haemodiafiltration during and after cardiopulmonary bypass in renal failure patients
12. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy
13. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding
14. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation
15. Regional citrate anticoagulation in continuous venovenous hemodiafiltration
16. Low-molecular-weight-heparin
17. Prostacyclin (PGI2): New aspects of an old substance in the treatment of critically ill patients
18. Heparin and prostacyclin in hemofiltration after orthotopic liver transplantation
19. Use of prostacyclin as the only anticoagulant during continuous venovenous hemofiltration
20. Anticoagulation for continuous arteriovenous hemofiltration in children
21. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration
22. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit
23. Prevalence and clinical outcome associated with pre-existing malnutrition in acute renal failure: A prospective cohort study
24. Predicting patient outcome from acute renal failure comparing three general severity of illness scoring systems
25. Incidence, risk factors and prognosis of gastrointestinal hemorrhage complicating acute renal failure
26. APACHE II: A severity of disease classification system
27. Risk factors for gastrointestinal bleeding in critically ill patients
28. Operating characteristics of hollow-fiber dialyzers
29. Effect of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomized trial
30. Maintaining blood flow in the extracorporeal circuit: Haemostasis and anticoagulation
31. Nadroparin versus dalteparin anticoagulation in high-volume continuous venovenous hemofiltration: A double-blind, randomized, crossover study
32. Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure
33. Proximally delivered dilute heparin does not improve circuit life in continuous venovenous haemodiafiltration
34. Factors affecting system clotting in continuous renal replacement therapy: Results of a randomized, controlled trial
35. Continuous hemofiltration and platelet function in critically ill patients
36. Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy
37. A protocol-based treatment for intradialytic hypotension in hospitalized hemodialysis patients
38. Impact of sodium and ultrafiltration profiling on hemodialysis-related symptoms
39. Preventing dialysis hypotension: A comparison of usual protective maneuvers
40. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients
41. Transfusion requirements during continuous veno-venous haemofiltration: The importance of filter life
42. Coagulation disorders in acute renal failure
43. Anticoagulant-induced thrombosis
44. Heparin-associated thrombocytopenia during continuous venovenous hemofiltration
45. Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit
46. Bleeding after intermittent or continuous r-hirudin during CVVH